Viking Therapeutics Inc – Bilanz (NASDAQ:VKTX) | MetaTrader

Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Gesamtvermögen 256.5 M210.66 M168.53 M368.49 M908.32 M715.73 M Gesamtverbindlichkeiten 12.16 M8.78 M23.21 M20.07 M28.04 M76.67 M Gesamtkapital 244.34 M201.88 M145.32 M348.42 M880.28 M639.06 M Gesamtverbindlichkeiten und Eigenkapital 256.5 M210.66 M168.53 M368.49 M908.32 M715.73 M Gesamtverschuldung —————— Nettoverschuldung ——————

Nachrichten

Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider

Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

Viking Therapeutics, Inc. (VKTX) Surpasses Market Returns: Some Facts Worth Knowing

NVO Crashes 36% in 3 Months: Is This an Indication to Sell the Stock?

LLY Launches GLP-1 Pill, Expands Access Through Pharmacy Partnerships

3 Best Stocks Under $50 to Buy in April 2026, According to Analysts - TipRanks.com

Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?

WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks

VKTX Finishes Enrollment in Second Late-Stage Study on Obesity Drug

Klinische Fortschritte: William Blair stuft Viking Therapeutics weiterhin mit "Outperform" ein

Morgan Stanley bestätigt Rating für Viking Therapeutics nach Studienfortschritt